How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system?

Aiming at understanding the molecular properties of the encapsulation of the anticancer drug gemcitabine in the single-walled carbon nanotube (SWCNT), molecular dynamics (MD) simulations were applied to the two scenarios; that of gemcitabine filling inside the SWCNT, and that of the drug in the free state. Inside the SWCNT, the cytosine ring of gemcitabine was found to form a π-π stacking conformation with the SWCNT surface, and this movement is not along the centerline of the tube from one end to the other of the tube where the distance from the center of gravity of the molecule to the surface is 4.7 Å. A tilted angle of 19° was detected between the cytosine ring of gemcitabine and the inner surface of SWCNT. In comparison to its conformation in the free form, no significant difference was observed on the torsion angle between the five- (ribose) and the six- (cytosine) membered rings. However, gemcitabine inside the SWCNT was found to have a lower number of solvating water molecules but with a stronger net solvation than the drug in the free state. This is due to the collaborative interactions between gemcitabine and the surface of the SWCNT. In addition, the steered molecular dynamics simulation (SMD) approach was employed to investigate the binding free energy for gemcitabine moving from one end to another end throughout the SWCNT. In excellent agreement with that yielded from the classical MD, the SMD energy profile confirms that the drug molecule prefers to locate inside the SWCNT.

[1]  S. Iijima.  Helical microtubules of graphitic carbon , 1991, Nature.

[2]  Maurizio Prato,et al.  Double functionalization of carbon nanotubes for multimodal drug delivery. , 2006, Chemical communications.

[3]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[4]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD on the IBM Blue Gene/L system , 2008, IBM J. Res. Dev..

[5]  V. Colvin.  The potential environmental impact of engineered nanomaterials , 2003, Nature Biotechnology.

[6]  Hongjie Dai,et al.  Supramolecular Chemistry on Water- Soluble Carbon Nanotubes for Drug Loading and Delivery , 2007 .

[7]  Xiaoke Zhang,et al.  Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. , 2009, Biomaterials.

[8]  Malcolm L. H. Green,et al.  Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.

[9]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[10]  M. Prato,et al.  Can Carbon Nanotubes be Considered Useful Tools for Biological Applications? , 2003 .

[11]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[12]  K. Leong,et al.  Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. , 2005, Angewandte Chemie.

[13]  Darren J. Martin,et al.  THE BIOCOMPATIBILITY OF CARBON NANOTUBES , 2006 .

[14]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[15]  G. Tulunay,et al.  Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma , 2006, Expert review of anticancer therapy.

[16]  H. Dai,et al.  Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. , 2007, Journal of the American Chemical Society.

[17]  Carbon nanotubes in cancer therapy , 2008 .

[18]  Maurizio Prato,et al.  Functionalized Carbon Nanotubes in Drug Design and Discovery , 2008 .

[19]  W. E. Billups,et al.  Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. , 2006, Toxicology letters.

[20]  L. Yahia,et al.  Biocompatibility and applications of carbon nanotubes in medical nanorobots , 2007, International journal of nanomedicine.

[21]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[22]  Stanislaus S. Wong,et al.  Covalent Surface Chemistry of Single‐Walled Carbon Nanotubes , 2005 .

[23]  M. Prato,et al.  Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. , 2007, Nature nanotechnology.

[24]  A. Cuschieri,et al.  Can the properties of carbon nanotubes influence their internalization by living cells , 2008 .

[25]  Baohua Ji,et al.  Structure-based design of carbon nanotubes as HIV-1 protease inhibitors: atomistic and coarse-grained simulations. , 2010, Journal of molecular graphics & modelling.

[26]  K. Schulten,et al.  Steered molecular dynamics studies of titin I1 domain unfolding. , 2002, Biophysical journal.

[27]  M. Prato,et al.  Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. , 2003, Journal of the American Chemical Society.

[28]  Nopporn Kaiyawet,et al.  Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and Venezuelan equine encephalitis viruses: molecular dynamics simulations and free energy calculations. , 2010, Journal of molecular graphics & modelling.

[29]  H. Kataura,et al.  Light-harvesting function of β -carotene inside carbon nanotubes , 2006 .

[30]  Huajian Gao,et al.  Spontaneous insertion of DNA oligonucleotides into carbon nanotubes , 2003 .

[31]  T. Straatsma,et al.  THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .

[32]  H. Kataura,et al.  Highly Stabilized β‐Carotene in Carbon Nanotubes , 2006 .

[33]  Maurizio Prato,et al.  Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. , 2003, Chemistry & biology.

[34]  H. Dai,et al.  Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.

[35]  M. Prato,et al.  Biomedical applications of functionalised carbon nanotubes. , 2005, Chemical communications.

[36]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[37]  Hongjie Dai,et al.  siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. , 2007, Angewandte Chemie.

[38]  M. Prato,et al.  Translocation of bioactive peptides across cell membranes by carbon nanotubes. , 2004, Chemical communications.

[39]  Supot Hannongbua,et al.  On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9. , 2007, Biophysical journal.

[40]  Zhuang Liu,et al.  Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. , 2005, Journal of the American Chemical Society.

[41]  M. Prato,et al.  Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. , 2006, Biochimica et biophysica acta.

[42]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[43]  Thanyada Rungrotmongkol,et al.  Understanding of known drug‐target interactions in the catalytic pocket of neuraminidase subtype N1 , 2008, Proteins.

[44]  Chenyu Wei,et al.  Adhesion and reinforcement in carbon nanotube polymer composite , 2006 .

[45]  A. Soh,et al.  Investigation of non-covalent association of single-walled carbon nanotube with amylose by molecular dynamics simulation , 2005 .